Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia.

[1]  Danilo Roman-Campos,et al.  Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Nav1.5 depends on the extracellular pH. , 2023, European journal of pharmacology.

[2]  D. Roman-Campos,et al.  Evaluation of right atrium structure and function in a rat model of monocrotaline‐induced pulmonary hypertension: Exploring the possible antiarrhythmic properties of amiodarone , 2023, Clinical and experimental pharmacology & physiology.

[3]  D. Roman-Campos,et al.  Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline‐induced pulmonary hypertension , 2023, Basic & clinical pharmacology & toxicology.

[4]  S. Zhai,et al.  Drug-induced torsades de pointes: Disproportionality analysis of the United States Food and Drug Administration adverse event reporting system , 2022, Frontiers in Cardiovascular Medicine.

[5]  D. S. Souza,et al.  Experimental hypothyroidism induces cardiac arrhythmias and ranolazine reverts and prevents the phenotype. , 2022, Life sciences.

[6]  A. Santos-Miranda,et al.  Ethnic-Related Sodium Voltage-Gated Channel α Subunit 5 Polymorphisms Shape the In Vitro Pharmacological Action of Amiodarone upon Nav1.5 , 2021, Molecular Pharmacology.

[7]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[8]  A. Santos-Miranda,et al.  Effects of amiodarone on rodent ventricular cardiomyocytes: Novel perspectives from a cellular model of Long QT Syndrome Type 3. , 2020, Life sciences.

[9]  J. Cruz,et al.  Reactive oxygen species and nitric oxide imbalances lead to in vivo and in vitro arrhythmogenic phenotype in acute phase of experimental Chagas disease , 2020, PLoS pathogens.

[10]  M. Rocchetti,et al.  Late sodium current and intracellular ionic homeostasis in acute ischemia , 2017, Basic Research in Cardiology.

[11]  L. Belardinelli,et al.  Inhibitions of late INa and CaMKII act synergistically to prevent ATX-II-induced atrial fibrillation in isolated rat right atria. , 2016, Journal of molecular and cellular cardiology.

[12]  C. Di Mario,et al.  The evolving landscape of oral anti-arrhythmic prescriptions for atrial fibrillation in England: 1998-2014. , 2016, European heart journal. Cardiovascular pharmacotherapy.

[13]  G. Fishman,et al.  Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3 , 2015, Scientific Reports.

[14]  A. George,et al.  Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy. , 2014, Heart rhythm.

[15]  K. Koskinas,et al.  Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  Nobuaki Kobayashi,et al.  Clinical significance of acid-base balance in an emergency setting in patients with acute heart failure. , 2012, Journal of cardiology.

[17]  C. Du,et al.  Pharmacological Inhibition of the hERG Potassium Channel Is Modulated by Extracellular But Not Intracellular Acidosis , 2011, Journal of cardiovascular electrophysiology.

[18]  R. Passman,et al.  Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting. , 2011, The American journal of cardiology.

[19]  Andrew L. Miller,et al.  Calcium signaling in cardiac myocytes. , 2011, Cold Spring Harbor perspectives in biology.

[20]  J. Rougier,et al.  Selective inhibition of persistent sodium current by F 15845 prevents ischaemia‐induced arrhythmias , 2010, British journal of pharmacology.

[21]  A. Leenhardt,et al.  Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity. , 2009, British journal of clinical pharmacology.

[22]  J. M. Di Diego,et al.  Atrial-selective effects of chronic amiodarone in the management of atrial fibrillation. , 2008, Heart rhythm.

[23]  Charles Antzelevitch,et al.  Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes. , 2007, American journal of physiology. Heart and circulatory physiology.

[24]  E. Crampin,et al.  A dynamic model of excitation-contraction coupling during acidosis in cardiac ventricular myocytes. , 2006, Biophysical journal.

[25]  J. Nerbonne,et al.  Molecular physiology of cardiac repolarization. , 2005, Physiological reviews.

[26]  J. Somberg,et al.  The Influence of Extracellular Acidosis on the Effect of IKr Blockers , 2005, Journal of cardiovascular pharmacology and therapeutics.

[27]  C. Orchard,et al.  Electrophysiological response of rat atrial myocytes to acidosis. , 2002, American journal of physiology. Heart and circulatory physiology.

[28]  C. Orchard,et al.  Electrophysiological response of rat ventricular myocytes to acidosis. , 2002, American journal of physiology. Heart and circulatory physiology.

[29]  V. Maltsev,et al.  Late sodium current is a novel target for amiodarone: studies in failing human myocardium. , 2001, Journal of molecular and cellular cardiology.

[30]  T. Bouillon,et al.  Population pharmacokinetics of long‐term oral amiodarone therapy , 2000, Clinical pharmacology and therapeutics.

[31]  J. Papp,et al.  Comparison of the chronic and acute effects of amiodarone on the calcium and potassium currents in rabbit isolated cardiac myocytes , 1996, British journal of pharmacology.

[32]  A. George,et al.  Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.

[33]  S. Cannon,et al.  Loss of Na+ channel inactivation by anemone toxin (ATX II) mimics the myotonic state in hyperkalaemic periodic paralysis. , 1993, The Journal of physiology.

[34]  T. Campbell,et al.  Lidocaine Shows Greater Selective Depression of Depolarized and Acidotic Myocardium than Propafenone: Possible Implications for Proarrhythmia , 1993, Journal of cardiovascular pharmacology.

[35]  M. Bonati,et al.  Physicochemical and analytical characteristics of amiodarone. , 1984, Journal of pharmaceutical sciences.

[36]  H. Hirche,et al.  Myocardial extracellular K+ and H+ increase and noradrenaline release as possible cause of early arrhythmias following acute coronary artery occlusion in pigs. , 1980, Journal of molecular and cellular cardiology.

[37]  OUP accepted manuscript , 2022, European Heart Journal: Acute Cardiovascular Care.

[38]  J. Ruskin,et al.  Augmentation of late sodium current unmasks the proarrhythmic effects of amiodarone. , 2008, Cardiovascular research.